[HTML][HTML] Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed tomography after nivolumab treatment in a patient with indolent …

E Alagoz, S Ince, K Okuyucu, A Ayan… - Translational Cancer …, 2016 - tcr.amegroups.org
Most patients with Hodgkin lymphoma (HL) get a remission after induction chemotherapy
with or without radiation therapy (RT). However, relapse rates range from 10–20% in cases …

Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed tomography after nivolumab treatment in a patient with indolent Hodgkin …

E Alagoz, S Ince, K Okuyucu, A Ayan… - Translational Cancer …, 2016 - tcr.amegroups.org
Most patients with Hodgkin lymphoma (HL) get a remission after induction chemotherapy
with or without radiation therapy (RT). However, relapse rates range from 10–20% in cases …

[PDF][PDF] Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed tomography after nivolumab treatment in a patient with indolent …

E Alagoz, S Ince, K Okuyucu, A Ayan… - Translational Cancer …, 2016 - cdn.amegroups.cn
Most patients with Hodgkin lymphoma (HL) get a remission after induction chemotherapy
with or without radiation therapy (RT). However, relapse rates range from 10–20% in cases …

[引用][C] Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed tomography after nivolumab treatment in a patient with indolent …

E Alagoz, S Ince, K Okuyucu, A Ayan, H San… - Translational Cancer …, 2016 - cir.nii.ac.jp
Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed
tomography after nivolumab treatment in a patient with indolent Hodgkin lymphoma | CiNii …